Asrar AlAhmadi, MD, MAS-CR (أسرار) Profile Banner
Asrar AlAhmadi, MD, MAS-CR (أسرار) Profile
Asrar AlAhmadi, MD, MAS-CR (أسرار)

@AsrarAlahmadi

Followers
1,110
Following
2,349
Media
29
Statuses
812

Assistant Professor and Thoracic Medical Oncologist @OSUCCC_James #LCSM #SCLC

Columbus, OH
Joined January 2012
Don't wanna be here? Send us removal request.
Explore trending content on Musk Viewer
Pinned Tweet
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
5 years
PDG 9: conquering lung cancer together at #vailWorkshop19 . What an amazing team, developing innovative protocols to help patients with #lungcancer . @AACR @ASCO @IASLC @deanpost @JPatelMD @DrRoyHerbstYale @YaleCancer @caseccc @StanfordMed @CaseUHmed
Tweet media one
0
1
36
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
5 years
@RubaSufi كان كريم مع أهل بيته و مع الناس. كان أب للجميع كلنا نعرف عبدالقدوس، و له من اسمه نصيب طاهر القلب و الخلق، المترفع عن ما لا يليق به. الهي يجبر كسركم و يرزقكم بر والديكم بعملكم الصالح و علمكم صدقه
0
2
27
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
5 years
Starting #FDA_ASCOFellowsDay strong. It’s very nice to see friends from #VAIL19 and around US. @FDAOncology @ASCO
Tweet media one
0
2
24
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
5 years
Beyond thrilled and honored for the #VailWorkshop19 opportunity!! A lot of learning pearls and fun work w new friends and awesome mentors! @AACR @ASCO @caseccc @JPatelMD @DrRoyHerbstYale
@DrRoyHerbstYale
Roy Herbst
5 years
Excited to be in Vali ⁦ @AACR ⁩ ⁦ @ASCO ⁩ at the annual methods in clinical cancer research course. Working with lung cancer focused Group 9 to develop protocols with co-mentors Jyoti Patel, Mary Redman and Pam Moffitt. ⁦ @YaleCancer ⁩ ⁦⁦⁦ @YaleMedicine
Tweet media one
2
4
60
0
4
16
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
5 years
Congratulations to Dr. Timothy Yap, the recipient of the prestigious Michaele C. Christian Oncology Drug Development Award by @NCICTEP_ClinRes . A great end to a great meeting #EDD19 @MDAndersonNews @MDAndersonTrial
Tweet media one
Tweet media two
Tweet media three
1
3
15
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
4 years
Happy to share our view on #clinicaltrial design in #SCLC . The challenge of discovering therapeutic vulnerabilities and designing optimal clinical trial in ChemoR vs Sensitive population. Slicing and dicing small cell lung cancer to improve trial outcomes
1
1
13
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
5 years
Proud of my friend @arkhaki for receiving @ASCO @ConquerCancerFd merit Awad. Important work studying End of life care in cancer patients under great mentor @gary_lyman . Congratulations!!
@ASCO
ASCO
5 years
. @ConquerCancerFd recognizes 12 oncology professionals with merit awards for their abstracts being presented next week at #ASCOQLTY19 . Congrats to all!
3
8
31
1
1
13
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
4 years
@abbyCCim I was given a chance 6 years ago. A PD looked beyond my scores, alumni, nationality and accomplishments on paper. He saw my authentic self and potential, and opened the door for me. How many are committed to look beyond the criteria?
1
1
13
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
5 years
It was such an honor to meet @SandraSwainMD . She was generous discussing her career; the successes and obstacles that shaped her path. Thank you for the career and life advices. Most of all THANK YOU for always amplifying #WomenInMedicine @ASCO @CCR_AACR . @LombardiCancer @caseccc
@cwruim
Case Western/UH IM Chiefs
5 years
We are fortunate to have Dr. @SandraSwainMD presenting at our 18th Annual Jack Berman lecture. #cwruim #breastcancerawareness
Tweet media one
Tweet media two
0
0
7
0
2
10
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
4 years
سعيدة جدا بانتخاب زملائي من كلية الصيدلة لقيادة المجموعة المتخصصة بجمعية @SSCP_KSA . هم قادة المستقبل بلا شك و كلى ثقة بمستقبل مشرق للجميع. @GhazwaTbader @DrOhoudAljuhani @khalid_eljaaly2 بأذن الله أرى قسم الاورام مرفق قريبا لهذي الباقة، و موفقين.
2
1
10
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
2 years
Meeting @DrCelineFadel a promising woman coming to do great work in cancer disparities!! #sheforshe #ASCO22 #ASCOWNG
Tweet media one
1
0
9
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
5 years
Strong work by @StephenVLiu and team!! I’m proud of you @SushmaJonna , Kodus my friend !!
@StephenVLiu
Stephen V Liu, MD
5 years
#OncoAlert Formally published this week in @CCR_AACR is our report on #NRG1 fusions across tumors led by @SushmaJonna . Actionable fusion with trials open and in development; seen across tumor types including #NSCLC , CRC, cholangio, pancreatic and more.
5
36
97
0
0
9
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
5 years
We stand together, dance together, and Beat #cancer together. The end of the beginning !! #VailWorkshop2019 . @ASCO @AACR @DrMhidalgo
0
0
8
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
6 years
“Poverty is a Carcinogen” #CaDispCLE Great eye opening talk @drznahleh @caseccc
0
2
9
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
4 years
Thank you for the review @arkhaki !! I started listening to the audible version and I’m enjoying it so far!! @VPrasadMDMPH , as expected, eloquent writing.
@arkhaki
Ali Khaki
4 years
Finally putting together a review of Malignant by @VPrasadMDMPH
Tweet media one
1
4
14
0
2
9
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
4 years
The journey of breast cancer support gp “Najia” in Saudi Arabia. The unique challenges of a private community lead to the development of the WhatsApp Gp. Interested to hear similar initiatives in diff communities @arjazieh @guptaarjun90 @jillfeldman4 @ivybelkins @maryam_lustberg
@atlal_abusanad
د.أطلال أبوسند
4 years
“Najia” Story: A WhatsApp Support Group For Patients With Breast Cancer | Innovations in Digital Health, Diagnostics, and Biomarkers | Allen Press @InnoJournals #bcsm #survivorship @InnoJournals
Tweet media one
1
3
4
2
1
9
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
6 years
@marwanalhajeili @dryamani هناك تفاوت بين الدعم للتطور الطبي في المملكة ، باستثناء الرياض. اهو قصور، ضعف دعم ...؟. مستوى الحالات و العناية المقدمة في الرياض يوازي العناية بالولايات المتحدة و كندا. في المقابل جدة غنيه بخبراتها، شحيحة في دعمهم كما تفضلت. و يألمني اكثر وضع بقية أنحاء المملكة.
0
3
9
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
5 years
As always, an amazing tweetorial by @arghavan_salles summarizing a Ellen Zane lecture in #BE19 . The last 2 points are gold.
@arghavan_salles
Arghavan Salles, MD, PhD
5 years
The last two speak for themselves. Never, ever compromise the high road. Kill ‘me with competence. “It’s about courage and it’s about boldness bc if it were easy, anyone could do it.” 13/ #BE19
Tweet media one
Tweet media two
3
41
148
1
1
8
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
4 years
Thank you, @IDdocAdi , for shedding lights on a story many of us have. It touches deep to heart as I’ve been out of the USA for the last 6 months waiting for the visa process to join my new faculty position. Despite all obstacles, I/we will continue to preserve and fall forward.
@IDdocAdi
Adi
4 years
1. PASSED MY ID BOARDS!! You are now looking at a board certified ID physician! This ends a decade long journey in medical training as a Foreign Medical Graduate (FMG). This was a challenging & fulfilling journey, with many people to thank. My journey as an FMG, in a thread 🧵
Tweet media one
345
266
7K
3
2
8
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
4 years
Very much enjoyed reading this masterful piece by @oncology_bg . How #Covid -19 is giving us an opportunity to pause and re-evaluate our practice. #choose_wisely
@oncology_bg
Bishal Gyawali
4 years
Just OUT! Today in @JAMAOnc , we discuss that lessons in cancer care from COVID-19 should not be forgotten even post-pandemic. This paper has special meaning to me because it was my first opportunity to work with the inspirational @EAEisenhauer . #globalonc
Tweet media one
4
26
96
1
2
7
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
5 years
0
2
6
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
10 years
Give people Love not your 'likes' #LookUp 👍👍
0
0
6
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
2 years
Beautiful and historical win for the Arab world #FIFAWorldCup
@NaglaAKarimMD
Dr. Nagla Abdel Karim
2 years
What a great coincidence! In less than 24 hours after meeting with 2 of my colleagues who are from Saudi Arabia and are also Thoracic Medical Oncologists #MENA , Saudi wins in the World Cup against Argentina. #collaboration #Good_luck @AsrarAlahmadi
Tweet media one
Tweet media two
1
0
3
0
1
6
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
4 years
@ASCO Annual meeting always offered trainee opportunities for education and career development. This year the tradition will continue through multiple webinars and one-on-one mentoring👇🏼👇🏼
@ASCO
ASCO
4 years
📢 Our Trainee & Early Career Council has developed a portfolio of webinars and one-on-one #mentoring opportunities to support the #careerdevelopment needs of oncology #trainee & #earlycareer members 👉
Tweet media one
1
11
32
0
3
6
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
4 years
#lungscreen save lives. Start at age 50 & 20 pack yr minimum. The new update will broaden eligibility and decrease mortality. #LCSM
@sands_jacob
Jacob sands
4 years
Updated USPSTF #lungscreen ! Start age 50 & 20 pack yr minimum. Good data to support this! @lungassociation previously estimated 48k #lungcancer deaths/yr could be prevented by CT screen. This important update further increases lives to be saved! #LCSM
8
31
96
0
0
6
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
5 years
@jennybencardino @jennybencardino @arghavan_salles thank you thank you for starting this inspiring thread💜!!I also came alone at age of 24, and still alone w my family are behind seas. Your thread brought joy to my heart!! You both revealed great examples to the young generation. Hard work pays!
2
3
6
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
5 years
Many faces I had the privilege to work and learn from. Including @DrMarcosdelima and #Debra_Leizman . @CaseUHmed
@DanSimonMD
Daniel I. Simon, M.D.
5 years
44 @UHHospitals clinicians were designated Distinguished Physicians in recognition of their exceptional clinical skills & dedication to patient care. These physicians & surgeons join an elite group of 36 inducted last year as the 1st class of Distinguished Docs. Congratulations!
Tweet media one
0
6
63
0
0
5
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
4 years
@DoctorYazanA
Yazan Abou-Ismail, MD - د. يزن أبواسماعيل
4 years
Quite pleased with the @JVascSurg ‘s decision to retract the paper from Dec 2019, thanks to the #MedBikini backlash on Twitter.
1
0
8
0
1
5
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
4 years
An excellent commentary by @arkhaki @ADesaiMD @NicoleKuderer to the JAMA Case-Ctrl study using EMR @caseccc exploring risk factors/complications of COVID19 in patients with cancer and racial disparities.
0
3
5
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
4 years
Worth note the similarities between the new @FDAOncology Acc approval of Lurbinectedin based on single arm Phase II trial, and Amrubicin previous development that showed a similar response in Phase II, but failed in Phase III. I hope Lurbinectedin will have a different fate.
1
0
5
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
11 years
يا زين أهل أول http://t.co/g5IJxEJ00D
Tweet media one
7
13
4
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
5 years
@ArielaLMarshall @MVGutierrezMD @womeninmedchat I’m still in my training year, but I aim/want to be a leader. I learned since young age that women education and women in leadership position is the main way for equality. Helping each other to go up the ladder.
0
0
4
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
3 years
As we enter the 3rd year of COVID-19 the healthcare disparities become increasingly evident!! Joining @DrRobinYabroff and sharing #MLK : "Of all the forms of inequality, injustice in health is the most shocking and the most inhuman because it often results in physical death."
@ASCO
ASCO
3 years
A recording of @DrRobinYabroff 's #GI22 keynote address Impact of the COVID-19 Pandemic on Equity and Access to Care is now available to the public. Watch here!
0
6
7
0
1
4
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
5 years
Very nice tweetorial about utilization of broad NGS in metastatic breast cancer patients; association of NGS with clinical outcomes and patients/ providers perceptions. Strong work @StoverLab
@StoverLab
Daniel Stover, MD, FASCO
5 years
Somatic genomic testing is increasingly common in metastatic #BreastCancer What does it mean for patient care, outcomes, & perceptions? Our prospective decision analysis study – just out in @JCO_PO in time for #SABCS19 ! @maryam_lustberg @OSUCCC_James 1/
Tweet media one
4
14
56
0
0
4
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
4 years
@atlal_abusanad @arjazieh @emadshash @OncoAlert @BanerjeeSusana @SAUDIPSC @myESMO @SanaAlSukhun @weoncologists @OncologySaudi @MulaHussain Congratulations!! Interesting that gender, years in practice and practicing settings didn’t correlate w BT. Important first step to search for solutions!!
1
0
4
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
5 years
Science is wonderful!!
@JMGardnerMD
Jerad Gardner, MD
5 years
NK/T cell vs cancer cell. The immune system is amazing. #pathology #science .
41
2K
6K
0
1
4
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
3 years
Incredible 10 tips for early career by @AndrewJSauer !!
@AndrewJSauer
Andrew J Sauer MD
3 years
My top ten tips for graduating fellows and faculty entering and continuing “early career” as I am transitioning into “mid-career”. A thread:
91
458
2K
0
0
4
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
6 years
@JackWestMD @CharuAggarwalMD Thank you all. We look forward for more #JAMAOncJC
0
0
4
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
10 years
Cleveland for the next 3 years of my life.. I can't be Thrilled more❤️. Thank you Allah, Thx to my Friends& Family.. Let the Journey start💪
5
2
4
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
4 years
1
0
3
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
5 years
@StephenVLiu @ASCO @AACR I see a lot of great minds, And 2 of my great mentors: Afshin Dowlati, and Michelle Treasure.
0
0
2
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
5 years
@mjayoushe Im impressed with you resilience. A strong women like will reach her goals very soon!!
1
0
3
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
5 years
Learning about different types of expanded access programs in FDA, when and how?. Multiple efforts to hasten the approval of safe and effective therapies in the area of Oncology. #FDA_ASCOFellowsDay @FDAOncology @ASCO .
Tweet media one
0
1
3
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
5 years
Wonderful summary of post genetic testing counseling for risk reduction #ASCO19 #GENETICS #Genomics workshop
Tweet media one
0
1
3
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
17 days
@DrBassemKurdi اش اسباب النظام الحالي وليش مستمر-سنين التدريب هي استثمار في طبيب حيرعى المجتمع ل٢٠-٣٠ سنه قدام.صعب أتخيل انه في أطباء اضطرّوا للقبول بسنين تدريبهم من غير رواتب، او اضطرّوا يضحو بقبول عشان مافي وظيفه/راتب. هل المستشفيات حقيقي ما ترى لهم قيمه مضافه بتوفير وظايف خلال زمن التدريب!
3
0
3
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
4 years
Very informative tweetorial about recent FDA agnostic approval for pembro in hTMB >10 utalizaing F1 companion test. @AmitKulkarniMD I agree hTMB is cancer dependent, still happy with FDA approval giving more options to patients w rare histologies and limited options.
@AmitKulkarniMD
Amit Kulkarni
4 years
#FDA recently approved #pembrolizumab - a tissue agnostic indication in metastatic tumors with high #TMB (>10 mut/MB) using Foundation One Dx companion diagnostic test. I want to share a tweetorial on why this indication could be problematic and hope to share some nuances on #TMB
12
115
243
0
1
3
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
4 years
0
0
3
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
5 years
@sepideh_gholami Your story!! it’s not only brave, but awe-inspiring !! Many are proud of u, including me!! #RoleModel
0
0
3
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
4 years
@guptaarjun90 Very nice and important work. Not just pointing the issue, but trying to identify physician factors. 👏🏼
1
0
3
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
6 years
@LinahSofi @hellosunshine In highly competitive sectors; as sport, if a male had a similar reaction, it’s simply passion, toughness, a competitive spirit blah blah blah!! For women it’s conceived differently; bossy, tantrum, can’t accept defeat... etc. I don’t give her an excuse,but I KNOW THE FEELING!!
0
0
2
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
4 years
0
0
3
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
4 years
@inas_md @HemOncWomenDocs You are making her proud everyday 💜
0
0
3
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
4 years
“As isolating as medical training can be during the difficult months of this pandemic, I am incredibly grateful to have truly found my tribe” a great piece as usual by @inas_md 💪🏼
@inas_md
Inas Abuali, MD
4 years
My latest @ASCO column on the positive impact of utilizing @Twitter as a Heme/Onc fellow. #MedTwitter #AcademicTwitter A special thanks to @DrErin_DO ❤️ <Yes, I have gone from “I am never creating an account to I will blog about much I love it”>🤣 1/
2
16
63
1
0
3
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
5 years
@GitaSuneja @dr_tvt @kelseycorrigan @DukeMedSchool @sloan_kettering @MDAndersonNews Impressive work, highlighting main barriers of care that we can overcome by implementing a better supporting system.
0
0
2
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
5 years
I’m so Proud of you @yabdouMD !! Very well deserved!!
@PgambarRaj
Paigambar Raj
5 years
Super excited to attend my first ESMO Congress this year in Barcelona! Very grateful for receiving a Merit Award and travel grant for my upcoming oral presentation (details below). Thank you @myESMO for supporting young oncologists! Join me on Sep 28th if you’ll be there! #ESMO19
Tweet media one
Tweet media two
3
5
52
1
0
3
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
2 years
@bpiperdi My condolences to you and your family. May Allah grant you Sabr. May Allah grant him forgiveness and paradise.
0
0
2
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
5 years
@ta_sussman @ClevelandClinic @FunchainMD Congratulations!! A big milestone
0
0
3
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
5 years
@tmprowell @deanpost @Merregan @DrMhidalgo @JPatelMD I just arrived to Denver, for the #VailWorkshop19 !! Thrilled to Attend , and I was hoping to meet you in person. I will follow you “e-mentoring “ tweets, and started by adding JCO paper to my ref. ;)
1
0
3
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
11 years
I have a hard time to distinguish between boredom and hunger!!
1
0
3
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
1 year
@thenasheffect @JCO_ASCO @TalalZarif1 @AminNassarMD @adib_elio @sonpavde @DrJFriedberg @EladSharonMD Very nice work. Congratulations to all!! Such collaboration indeed requires the Nash Effect ;)
1
0
2
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
4 years
A very nice review that highlights the challenge of post Osi treatment for EGFR mut NSCLC in the current era. #LCSM #EGFR @EGFRSummit
@apipervallillo
AJ Piper-Vallillo, MD
4 years
Excited to share our review “Emerging Treatment Paradigms for EGFR-Mutant Lung Cancers Progressing on Osimertinib,” synthesizing results of existing post-osi series to guide providers in sequencing next line therapies. @JCO_ASCO @EGFRResisters @LeciaSequist @ZPiotrowskaMD #LCSM
Tweet media one
7
35
98
0
0
2
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
4 years
@AishaFIYB Congratulations and best of luck!!
1
0
2
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
5 years
This thread 👇🏼!! It’s long but must read for women in #STEM . Thank you @choo_ek for eloquently pointing the hurdles we face to advance our career.
@choo_ek
Esther Choo, MD MPH
5 years
There’s another piece of this I’ve been reflecting on, which has to do with the fact that we’ve had close to 50% female medical school classes for about 30 years. 1/bunch
17
166
527
0
0
2
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
6 years
@DrAhmedAlShehri لا تحزن اليوم في عيادتي نصف اليوم رأيت ١١ مريض. الله يقوي الطبيب المتدرب و يقويك. لاعتبارات كثيرة عدد المرضى زاد و لكل مريض ٢٠ دقيقه للمتابعه، نسعى لايصالها بجودة، و هي على حساب الكادر الصحي بالغالب.
0
2
2
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
5 years
@YAbdouMD @TranMDPhD Wonderful pictures. I’m glad we finally met
1
0
2
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
3 years
@Reem_LM و الوجود انواع. في وجود في المكان و في وجود في القلب. يا هناكي لو اللي في القلب متواجدين في نفس المكان. بس صدقيني الناس لبعض. و عشانك طيبة حتلاقي ناس لاكانو في القلب و لا المكان جنبك.
0
0
2
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
5 years
@mmamas1973 @mirvatalasnag I wish I was able to attend in person. Thanks for sharing slides for an important topic. @mirvatalasnag you make us proud !! #WomenInSTEM
1
0
2
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
5 years
1
0
2
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
4 years
@AmitKulkarniMD @UMNHOT Congratulations @AmitKulkarniMD !! All the best :)
1
0
2
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
6 years
@VincentRK
Vincent Rajkumar
6 years
Latest in our series of Current Treatment Algorithms: Myelofibrosis - Authored by Ayalew Tefferi - the preeminent expert in this disease #OpenAccess #BCJ Blood Cancer Journal @DrMiguelPerales @Mohty_EBMT @mtmdphd @BldCancerDoc @doctorpemm
Tweet media one
Tweet media two
Tweet media three
2
25
28
0
0
2
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
3 years
@PatelOncology @RenoHemonc @montypal @MOASC_Office In immunotherapy induced hepatitis when do you use MMF vs Vedo? And have you ever used thymoglobulin.
1
0
2
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
5 years
0
0
2
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
5 years
@jennybencardino @Naomi_Osaka_ @CocoGauff She is setting a good example for who women should support each other. I love it 💜
0
1
2
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
5 years
Congratulations to the best PD ever!! You shaped our path to success 🙏 @cwru @CaseUHmed @UHhospitals @keitharmitage @AAIMOnline
@cwruim
Case Western/UH IM Chiefs
5 years
Congratulations to @keitharmitage on receiving the #APDIM19 Dema Daley Founders Award! You truly are one of the best part of @CaseUHmed and your residents, chief residents, and APDs thank you for all you do/have done. #ThankYou #RoleModel @CWRUdeptMED
Tweet media one
Tweet media two
Tweet media three
2
14
50
0
0
2
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
6 years
Nice review of IO/ genomic correlation
@VanAllenLab
Eli Van Allen
6 years
New from rising stars @TanyaEKeenan (computational oncology/breast cancer) & Kelly Burke (immunology/Sharpe Lab), we surveyed the current state of cancer genomics & immune checkpoint blockade - there's a lot going on 😀 @NatureMedicine @DanaFarber
2
67
168
0
1
2
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
5 years
@ta_sussman @FunchainMD @ClevelandClinic Amazing job my friend 🙌🏼!!!
0
0
2
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
4 years
@changkim211 @hopkinsheart Congratulations 🎊
0
0
2
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
6 years
Tweet media one
0
0
2
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
5 years
Wonderful thread by @NicoleKuderer !! With many Pearls of wisdom for young oncologist.
@NicoleKuderer
Nicole Kuderer, MD, MS, FASCO 🌎🇺🇸🇪🇺🇺🇦🌏
5 years
@oncology_bg @ASCO @JackWestMD @barttels2 @GlopesMd @EnriqueSoto8 @scottrberry @WilliamDale_MD @QueensCRI @chadinabhan @PORTAL_Research 1 #Tox / This is very personal to me what you do Bishal. What at 1. made me reject oncology as a specialty & then got me fully committee to make a difference in onc was: Following along, as a young, impressionable teenager, my favorite uncle through his 2 tandem transplants...
1
3
11
0
0
2
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
5 years
@sepideh_gholami @DrPrathima Absolutely agree, that applies to all specialties and jobs. As we evolve in our career/life, our perspectives and needs change too.
0
0
2
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
4 years
@DrSteveMartin @bpiperdi I saw a similar case w MSI-H. Pt maintained durable CR for 2 years now on Nivo. Interestingly he is still smoking!!
0
0
2
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
2 months
2
0
2
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
3 years
0
0
2
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
5 years
@atlal_abusanad In the era of biomarker driven therapy, I am more inclined to use them with poorer PS, Specially in young Pt. The latest generation of biomarker driven therapy are with high selective on target effect, with lesser off target SE.
0
0
2
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
10 years
Niagra Falls, NY http://t.co/TeDwvBIEHq
Tweet media one
0
0
2
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
11 years
بين منطوق لم يُقصَد، ومقص��د لم يُنطَق، تضيع الكثير من المحبة. #جبرانيات
1
3
2
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
4 months
@noha_soror @ASCO @elbairikhalid19 @ASCOTECAG @IMG_Oncologists @ResearchOU @hemeoncfellow @HemOncFellows Thank you @noha_soror and @elbairikhalid19 on writing this Very nice paper pressing on the main challenges of clinical researcher in both LMIC and MENA region.
1
0
2
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
1 month
@StoverLab @royaryam @OSUCCC_James Thanks Dan 💐. @royaryam congrats, and were are lucky you are joining us
1
0
2
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
11 years
موتي أحسن!!! http://t.co/bNecNbdz96
Tweet media one
7
9
2
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
5 years
@YAbdouMD I enjoyed the read!! Proud of you girl 🙌🏼
1
0
2
@AsrarAlahmadi
Asrar AlAhmadi, MD, MAS-CR (أسرار)
10 years
I can't get enough from the new prince 💗, The best cuddle I saw in years 😍😍 #PrinceGeorge #Royals http://t.co/4v9Fug35jy
Tweet media one
1
1
2